Year: 2025
Type: review
Abstract: Immune thrombocytopenia (ITP) is an autoimmune disease, characterized by increased bleeding due to a reduced platelet count. The pathogenesis of ITP is very complex and involves autoantibody production and T-cell-mediated immune abnormalities. An imbalance of effector and regulatory CD4+ T cells and the breach of tolerance primarily cause ITP, leading to the dysfunctional development of autoreactive Th cells (including Th1, Th2, and Th17 cells) and Tregs. The loss of auto-platelet antigen tolerance in ITP results in autoantibody- and cytotoxic T-cell-mediated platelet clearance. T-cell-related genetic risk factors significantly influence the development and progression of this disease. New therapies targeting T cells have emerged as potentially effective cures for this disease. This review summarizes the role of T cells in ITP.
Source: Frontiers in Immunology
Authors: Siyuan Bu, Min Liu, Lu Yang, Pamela Lee, Heather Miller, Chan-Sik Park, Maria Byazrova, Alexander Filatov, Kamel Benlagha, Timo Gaber, Frank Buttgereit, Quan Gong, Zhimin Zhai, Chaohong Liu
Institutions: Tongji Hospital, Huazhong University of Science and Technology, Leibniz Association, Humboldt-Universität zu Berlin, German Rheumatism Research Centre, Charité – Universitätsmedizin Berlin, University of Hong Kong, Asan Medical Center, University of Ulsan, Federal Medical-Biological Agency, Université Paris Cité, Institut de recherche Saint-Louis, Yangtze University, Second Affiliated Hospital of Anhui Medical University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
Award: G5725024056
OpenAlex ID: W4407828892
